Progress Annals: Journal of Progressive Research

Results of the use of silodosin in acute urinary retention caused by Benign prostatic hyperplasia

Kasimov S.S

Tashkent Medical Academy, Uzbekistan, Tashkent.

Abdukarimov O.O

Tashkent Medical Academy, Uzbekistan, Tashkent. State institution "Republican Specialized Scientific and Practical Medical Center of Urology", Uzbekistan, Tashkent.

Keywords: acute urinary retention, prostate adenoma, silodosin

---

Abstract

The article provides .α-blockers are widely used to treat one of the most serious complications of benign prostatic hyperplasia (BPH), acute urinary retention (AUR). Experience with the use of a new uroselective α-adrenergic blocker, silodosin, approved for the treatment of patients with urinary disorders caused by BPH, is presented. Its pharmacological profile has a number of advantages, including the highest uroselectivity to date, rapid onset of effect, the ability to take a standard dose of 8 mg once a day, which does not require adjustment depending on age; possibility of simultaneous use with antihypertensive drugs.